Biomarkers and Molecular Diagnostics for Early Detection and Targeted Management of Sepsis and Septic Shock in the Emergency Department

J Appl Lab Med. 2019 Jan;3(4):724-729. doi: 10.1373/jalm.2018.027425. Epub 2018 Dec 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Biomarkers / blood
  • Clinical Decision-Making / methods
  • DNA, Bacterial / isolation & purification
  • DNA, Fungal / isolation & purification
  • DNA, Viral / isolation & purification
  • Data Science
  • Decision Support Systems, Clinical
  • Early Diagnosis*
  • Emergency Service, Hospital*
  • Host-Pathogen Interactions
  • Humans
  • Machine Learning
  • Molecular Diagnostic Techniques / methods*
  • RNA, Viral / isolation & purification
  • Sepsis / blood
  • Sepsis / diagnosis*
  • Sepsis / drug therapy
  • Sepsis / microbiology
  • Shock, Septic / blood
  • Shock, Septic / diagnosis*
  • Shock, Septic / drug therapy
  • Shock, Septic / microbiology
  • Time Factors
  • Time-to-Treatment
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Biomarkers
  • DNA, Bacterial
  • DNA, Fungal
  • DNA, Viral
  • RNA, Viral